GenMont Biotech (TPE:3164) Common Stock: NT$860.1 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:3164 GenMont Biotech Inc TPE:3164
83 GF Score
Price NT$16.30
GF Value NT$26.26
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is GenMont Biotech Common Stock?

GenMont Biotech TPE:3164 -1.21% 83 Common Stock is NT$860.1 Mil as of Dec. 2025. GuruFocus rates TPE:3164 with a GF Score™ of 83/100 and a GF Value™ of NT$26.26 (Significantly Undervalued). The stock has 5 warning signs investors should review.

GenMont Biotech's quarterly common stock declined from Jun. 2025 (NT$865.1 Mil) to Sep. 2025 (NT$860.1 Mil) but then stayed the same from Sep. 2025 (NT$860.1 Mil) to Dec. 2025 (NT$860.1 Mil).

GenMont Biotech's annual common stock stayed the same from Dec. 2023 (NT$865.1 Mil) to Dec. 2024 (NT$865.1 Mil) but then declined from Dec. 2024 (NT$865.1 Mil) to Dec. 2025 (NT$860.1 Mil).

GenMont Biotech Common Stock Historical Data

* Premium members only.

The historical data trend for GenMont Biotech's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GenMont Biotech Common Stock Chart

GenMont Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 863.71 863.71 865.11 865.11 860.10

GenMont Biotech Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 865.11 865.11 865.11 860.10 860.10
TPE:3164
83GF Score
GenMont Biotech Inc TPE:3164
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GenMont Biotech Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of NT$860.1 Mil mean?
GenMont Biotech (TPE:3164) has a Common Stock of NT$860.1 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on GenMont Biotech and its competitors.
Is GenMont Biotech's Common Stock too high?
GenMont Biotech's current Common Stock is NT$860.1 Mil. Overall, GenMont Biotech has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GenMont Biotech's Common Stock compare to VRTX and REGN?
GenMont Biotech's Common Stock of NT$860.1 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on GenMont Biotech and its competitors. GenMont Biotech's current Common Stock is NT$860.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GenMont Biotech stock overvalued right now?
Based on GuruFocus' analysis, GenMont Biotech (TPE:3164) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$26.26, compared to a current price of NT$16.30 — trading 37.9% below its estimated fair value. The current Common Stock is NT$860.1 Mil. GenMont Biotech's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For GenMont Biotech (TPE:3164), the current Common Stock is NT$860.1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GenMont Biotech (TPE:3164) Overvalued in 2026?

Based on GuruFocus' analysis, GenMont Biotech stock appears to be undervalued. The current stock price of NT$16.30 is trading 37.9% below its estimated GF Value™ of NT$26.26. GuruFocus considers GenMont Biotech to be Significantly Undervalued.

Key valuation signals for TPE:3164:

  • Common Stock: NT$860.1 Mil
  • GF Value™: NT$26.26 vs. price of NT$16.30 (37.9% below fair value)
  • GF Score™: 83/100 with 5 warning signs

No single metric tells the full story. See the TPE:3164 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GenMont Biotech Business Description

Address No. 8 Nanke 7th Road, Tainan Science and Technology Park, Shanhua District, Tainan, TWN, 741014
GenMont Biotech Inc is engaged in the research, development, manufacturing, and selling of a variety of probiotic supplements. The Group mainly engages in the manufacturing and selling of functional foods, its single operating segment.
83GF Score

Get the complete analysis for TPE:3164

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$16.30
Price
NT$26.26
GF Value